{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:26:39Z","timestamp":1765545999989},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2015,4,24]],"date-time":"2015-04-24T00:00:00Z","timestamp":1429833600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0124912","type":"journal-article","created":{"date-parts":[[2015,4,24]],"date-time":"2015-04-24T18:12:55Z","timestamp":1429899175000},"page":"e0124912","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Determination of Plasma Heparin Level Improves Identification of Systemic Mast Cell Activation Disease"],"prefix":"10.1371","volume":"10","author":[{"given":"Milda","family":"Vysniauskaite","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-J\u00f6rg","family":"Hertfelder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Oldenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Dre\u00dfen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Brettner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Homann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard J.","family":"Molderings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2015,4,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1756-8722-4-10","article-title":"Mast cell activation disease: a concise practical guide for diagnostic workup and therapeutic options","volume":"4","author":"GJ Molderings","year":"2011","journal-title":"J Hematol Oncol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.critrevonc.2014.09.001","article-title":"The genetic basis of mast cell activation disease\u2014looking through a glass darkly","volume":"93","author":"G Molderings","year":"2015","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.jaci.2011.04.037","article-title":"Mast cell activation syndrome: A newly recognized disorder with systemic clinical manifestations","volume":"128","author":"MJ Hamilton","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: A consensus proposal","volume":"157","author":"P Valent","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal","volume":"25","author":"P Valent","year":"2001","journal-title":"Leuk Res"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1365-2362.2007.01807.x","article-title":"Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria","volume":"37","author":"P Valent","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2567.2012.03627.x","article-title":"Systemic mast cell activation disease: the role of molecular genetic alterations in pathogenesis, heritability and diagnostics","volume":"137","author":"B Haenisch","year":"2012","journal-title":"Immunology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/bjh.12916","article-title":"Epidemiology of systemic mastocytosis in Denmark","volume":"166","author":"SS Cohen","year":"2014","journal-title":"Br J Haematol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jaci.2012.10.015","article-title":"Prevalence of indolent systemic mastocytosis in a Dutch region","volume":"131","author":"JJ van Doormaal","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"e76241","DOI":"10.1371\/journal.pone.0076241","article-title":"Familial occurrence of systemic mast cell activation disease","volume":"8","author":"GJ Molderings","year":"2013","journal-title":"PLoS One"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5315\/wjh.v3.i1","article-title":"A concise, practical guide to diagnostic assessment for mast cell activation disease","volume":"3","author":"LB Afrin","year":"2014","journal-title":"World J Hematol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1160\/TH11-05-0351","article-title":"Bleeding diathesis in patients with mast cell activation disease","volume":"106","author":"H Seidel","year":"2011","journal-title":"Thromb Haemost"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1478-3231.2008.01839.x","article-title":"New aspects of liver abnormalities as part of the systemic mast cell activation syndrome","volume":"29","author":"K Alfter","year":"2009","journal-title":"Liver Int"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1615\/JEnvironPatholToxicolOncol.v28.i3.30","article-title":"Effects of shear stress on intracellular calcium change and histamine release in rat basophilic leukemia (RBL-2H3) cells","volume":"28","author":"W Yang","year":"2009","journal-title":"J Environ Pathol Toxicol Oncol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.jbiomech.2012.11.014","article-title":"Mechanical loading promotes mast cell degranulation via RGD-integrin dependent pathways","volume":"46","author":"V Fowlkes","year":"2013","journal-title":"J Biomech"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1398-9995.2012.02809.x","article-title":"Tryptase and histamine metabolites as diagnostic indicators of indolent systemic mastocytosis without skin lesions","volume":"67","author":"JJ van Doormaal","year":"2012","journal-title":"Allergy"},{"key":"ref17","first-page":"552","article-title":"Ultrastructural localization of heparin to human mast cells of the MCTC and MCT types by labeling with antithrombin III-gold","volume":"69","author":"SS Craig","year":"1993","journal-title":"Lab Invest"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1369\/0022155412458927","article-title":"Mast cell proteoglycans","volume":"60","author":"E R\u00f6nnberg","year":"2012","journal-title":"J Histochem Cytochem"},{"key":"ref19","first-page":"148","article-title":"Occurrence and significance of endogenous heparin","volume":"10","author":"A Studer","year":"1954","journal-title":"Experientia"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1055\/s-0028-1087139","article-title":"Endogenous heparin","volume":"4","author":"LB Jaques","year":"1978","journal-title":"Semin Thromb Hemost"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1172\/JCI109613","article-title":"Isolation and characterization of heparin from human lung","volume":"64","author":"DD Metcalfe","year":"1979","journal-title":"J Clin Invest"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00019501-200212000-00007","article-title":"Endogenous heparin\u2014a protective marker in patients with myocardial infarction, Coron","volume":"13","author":"S W\u0142adys\u0142aw","year":"2002","journal-title":"Artery Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000059404","article-title":"Serum tryptase levels in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease","volume":"128","author":"WR Sperr","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.3109\/10428194.2012.763121","article-title":"Bone Marrow Mast cell burden and serum tryptase level as markers of response in patients with systemic mastocytosis","volume":"54","author":"A Quint\u00e1s-Cardama","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.iac.2006.05.010","article-title":"Diagnostic value of tryptase in anaphylaxis and mastocytosis","volume":"26","author":"LB Schwartz","year":"2006","journal-title":"Immunol Allergy Clin North Am"},{"key":"ref26","first-page":"282","article-title":"Serum tryptase levels and markers of renal dysfunction in a population with chronic kidney disease","volume":"23","author":"AE Sirvent","year":"2010","journal-title":"J Nephrol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1006\/meth.1997.0494","article-title":"Markers of mast cell degranulation","volume":"13","author":"AD Hogan","year":"1997","journal-title":"Methods"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000048184","article-title":"Surrogate markers of disease in mastocytosis","volume":"127","author":"C Akin","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1034\/j.1398-9995.2002.23767.x","article-title":"Urinary metabolites of histamine and leukotrienes before and after placebo-controlled challenge with ASA and food additives in chronic urticaria patients","volume":"57","author":"G Di Lorenzo","year":"2002","journal-title":"Allergy"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.cccn.2005.03.041","article-title":"Comparison of serum tryptase and urine N-methylhistamine in patients with suspected mastocytosis","volume":"359","author":"AW van Toorenenbergen","year":"2005","journal-title":"Clin Chim Acta"},{"key":"ref31","unstructured":"Ibelgaufts H. Mast Cells. In: COPE: Cytokines and Cells Online Pathfinder Encyclopaedia. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.copewithcytokines.de\/cope.cgi?key=mast%20cells\" xlink:type=\"simple\">http:\/\/www.copewithcytokines.de\/cope.cgi?key=mast%20cells<\/ext-link>. Accessed September 3, 2013."},{"key":"ref32","doi-asserted-by":"crossref","first-page":"5024","DOI":"10.4049\/jimmunol.181.7.5024","article-title":"Secretogranin III directs secretory vesicle biogenesis in mast cells in a manner dependent upon interaction with chromogranin A","volume":"181","author":"P Prasad","year":"2008","journal-title":"J Immunol"},{"key":"ref33","first-page":"453","article-title":"Immunocytochemical expression of Chromogranin A in mast cells in the canine paranasal sinus","volume":"164","author":"S Stefanov","year":"2013","journal-title":"Revue M\u00e9d V\u00e9t"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1136\/thx.2003.013573","article-title":"Plasma 9\u03b1,11\u03b2-PGF<sub>2<\/sub>, a PGD<sub>2<\/sub> metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma","volume":"59","author":"G Bochenek","year":"2004","journal-title":"Thorax"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.jaip.2014.06.011","article-title":"Mast cell activation syndrome: improved identification by combined determinations of serum tryptase and 24-hour urine 11\u00df-prostaglandin2\u03b1","volume":"2","author":"A Ravi","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12967-014-0213-2","article-title":"Prostaglandin D<sub>2<\/sub>-supplemented &quot;functional eicosanoid testing and typing&quot; assay with peripheral blood leukocytes as a new tool in the diagnosis of systemic mast cell activation disease: an explorative diagnostic study","volume":"12","author":"D Sch\u00e4fer","year":"2014","journal-title":"J Transl Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/297229a0","article-title":"Differential release of serotonin and histamine from mast cells","volume":"297","author":"TC Theoharides","year":"1982","journal-title":"Nature"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-065X.2007.00519.x","article-title":"Differential release of mast cell mediators and the pathogenesis of inflammation","volume":"217","author":"TC Theoharides","year":"2007","journal-title":"Immunol Rev"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1038\/leu.2013.227","article-title":"Clonal mast cell disease not meeting WHO criteria for diagnosis of mastocytosis: clinicopathologic features and comparison with indolent mastocytosis","volume":"27","author":"A Pardanani","year":"2013","journal-title":"Leukemia"},{"issue":"Suppl 1","key":"ref40","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.jaci.2007.12.268","article-title":"Elevated baseline tryptase levels in patients with mast cell activation syndromes without evidence of mastocytosis","volume":"121","author":"D Kassaba","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2010.02.019","article-title":"Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms","volume":"125","author":"I Alvarez-Twose","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000144042","article-title":"Prevention of mast cell activation disorder-associated clinical sequelae of excessive prostaglandin D(2) production","volume":"147","author":"JH Butterfield","year":"2008","journal-title":"Int Arch Allergy Immunol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-0029-1245707","article-title":"Evidence for mast cell activation in patients with therapy-resistant irritable bowel syndrome","volume":"49","author":"T Frieling","year":"2011","journal-title":"Z Gastroenterol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"AB117","DOI":"10.1016\/j.jaci.2012.12.1088","article-title":"Mast cell activation syndrome associated with elevation in serum tryptase or 24-hour urine 11\u00df-prostaglandin-F2\u03b1","volume":"131","author":"A Ravi","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-2249.2010.04287.x","article-title":"Raised tryptase without anaphylaxis or mastocytosis: heterophilic antibody interference in the serum tryptase assay","volume":"162","author":"R Sargur","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/MAJ.0b013e31821d41dd","article-title":"Polycythemia from mast cell activation syndrome: lessons learned","volume":"342","author":"LB Afrin","year":"2011","journal-title":"Am J Med Sci"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"950582","DOI":"10.1155\/2012\/950582","article-title":"Allergic mastocytic gastroenteritis and colitis: an unexplained etiology in chronic abdominal pain and gastrointestinal dysmotility","volume":"2012","author":"MA Akhavein","year":"2012","journal-title":"Gastroenterol Res Pract"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/j.1365-2362.2008.02047.x","article-title":"Clinical correlates of blood serotonin levels in patients with mastocytosis","volume":"38","author":"NM Kushnir-Sukhov","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"ref49","first-page":"AB132","article-title":"Whole blood serotonin levels in cutaneous mastocytosis, systemic mastocytosis and mast cell activation syndroms","author":"J Butterfield","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-0032-1306321","article-title":"Physiological, pathophysiological and therapeutic impact of the enteric serotonergic system","volume":"62","author":"GJ Molderings","year":"2012","journal-title":"Arzneimittelforschung"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.prostaglandins.2010.03.003","article-title":"Increased leukotriene E4 excretion in systemic mastocytosis","volume":"92","author":"JH Butterfield","year":"2010","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"ref52","first-page":"469","article-title":"The measurement of leukotrienes in urine as diagnostic option in systemic mastocytosis","volume":"62","author":"M Raithel","year":"2011","journal-title":"J Physiol Pharmacol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1136\/thx.2004.026641","article-title":"Monitoring mast cell activation by prostaglandin D2 in vivo","volume":"59","author":"SE Dahl\u00e9n","year":"2004","journal-title":"Thorax"},{"issue":"Suppl","key":"ref54","first-page":"1","article-title":"On the role of PGD2 metabolites as markers of mast cell activation in asthma","volume":"644","author":"S O\u2019Sullivan","year":"1999","journal-title":"Acta Physiol Scand"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.4049\/jimmunol.1101806","article-title":"Eosinophils as a novel cell source of prostaglandin D2: autocrine role in allergic inflammation","volume":"187","author":"T Luna-Gomes","year":"2011","journal-title":"J Immunol"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.prostaglandins.2009.01.001","article-title":"Survey of aspirin administration in systemic mastocytosis","volume":"88","author":"JH Butterfield","year":"2009","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/1523-1747.ep12606209","article-title":"Improved diagnosis of mastocytosis by measurement of the major urinary metabolite of prostaglandin D2","volume":"104","author":"JD Morrow","year":"1995","journal-title":"J Invest Dermatol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0124912","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T13:19:57Z","timestamp":1540214397000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0124912"}},"subtitle":[],"editor":[{"given":"Kottarappat N","family":"Dileepan","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,4,24]]},"references-count":57,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0124912","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,24]]}}}